WKN DE: A12ABF / ISIN: US1712691039

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Chugai Pharmaceutical Times and Sales (NASO)

Zeit	Kurs	Umsatz (Stk)
17:10:11	21,696	21
17:09:24	21,710	22
17:07:56	21,677	1
17:07:08	21,671	387
17:07:08	21,689	138
17:05:15	21,710	110
17:04:46	21,680	8
17:04:45	21,671	597
17:04:44	21,677	25
17:04:43	21,680	19
17:04:42	21,683	2
17:04:41	21,680	16
17:04:41	21,689	6
17:04:40	21,683	2
17:04:39	21,686	1
17:04:38	21,683	7
17:04:37	21,689	480
17:04:36	21,683	126
17:04:33	21,650	29
17:04:22	21,710	20
17:03:15	21,699	21
17:00:49	21,680	10
16:59:19	21,710	21
16:59:16	21,692	2
16:56:50	21,702	21
16:56:21	21,650	49
16:53:40	21,668	13
16:52:33	21,650	49
16:52:29	21,680	21
16:52:07	21,710	21
16:51:50	21,650	10
16:50:19	21,679	36
16:50:01	21,680	4
16:49:39	21,702	19
16:48:42	21,689	378

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Chugai Pharmaceutical Co Ltd Unsponsored American Deposit Receipt Repr 2 Shs

Weitere Meldungen

14:53		Walmart (WMT) Q2 2027 Earnings Call Transcript
14:53		Aurora Mobile (JG) Q2 2026 Earnings Call Transcript
14:52		Great Elm Group Reports Q4 2026 Results: Full Earnings Call Transcript
14:50		A $3,000 Investment Made in SpaceX Stock Today Could Be Worth This Much by August 2027
14:46		Top 3 Health Care Stocks That May Keep You Up At Night In Q3
14:45		Rackspace Scott Anthony Sells 48,780 Shares for $207,315
14:44		Gaotu Techedu Q2 2026 Earnings Call Transcript
14:41		Mark Zuckerberg’s Meta Agreed to a $17 Billion Settlement—Bernie Sanders Calls It a ‘Good Step Forward,’ But Says 'Much More Needs to Be Done' (UPDATED)
14:41		Jim Cramer Has a Message for Nvidia Investors After the Earnings Blowout: ‘Don’t Let the Bears Deceive You’ Into Selling NVDA
14:40		Peter Thiel Has Steadily Sold Down His Palantir Stake for Years, Yet Remains Its Largest Individual Shareholder. Here's What His Selling Pattern Signals for Investors.
14:39		Could new US sanctions tear China and Iran apart?
14:37		Scott Bessent (Un)Intentionally Made Two of Bitcoin's Strongest Arguments, Bitwise Exec Says
14:32		Dollar recoups some losses as focus shifts to Fed remarks at Jackson Hole
14:27		If You Invested $1,000 in D-Wave Quantum Stock 3 Years Ago, This Is How Much You Would Have Today
14:20		Baozun Q2 2026 Earnings Call: Complete Transcript
14:20		Hyperliquid Shares Jump After Fiscal-Year Results; HYPE Treasury Tops 29M Tokens
14:14		Dell Beat Last Quarter's EPS Estimate by 65% — Can It Repeat That Next Time?
14:12		Synopsys Boosts Annual Outlook as AI Complexity Drives Demand
14:11		Nvidia Surges 6% Premarket—These ETFs Are Amplifying the AI Trade
14:10		HP, Best Buy Dollar Tree And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
14:09		Camtek CEO Rafi Amit Sells 6,250 Shares for $1.1 Million
14:02		Stellenabbau und Kostensenkungen zeigen Wirkung bei KTM-Mutter Bajaj
14:02		Stellenabbau und Kostensenkungen zeigen bei KTM-Mutter Bajaj Mobility Wirkung
14:02		AstraZeneca, Amgen Score Phase 3 Win in Debilitating Swallowing Disease
14:00		Here’s how the private-listing war between Zillow and Compass could cost home buyers and sellers
14:00		Samsung’s $700 Galaxy S26 FE Is Better, but It’s Getting Harder to Call It a Bargain
14:00		Trump’s FCC Just Scrapped Its Most Ambitious Broadband Goal
14:00		Galaxy S26 FE: Warum Samsungs Fan Edition es schwer haben könnte
13:59		Did Meta’s Big Settlement Actually Help It?
13:58		Why Is Sandisk Stock Surging on Thursday?
13:48		Not Sandisk. Not Micron. This AI Semiconductor Powerhouse Could Be the Biggest Winner of the Memory Boom
13:46		Hugging-Face-Angriff: OpenAI-Abschlussbericht liefert neue Erkenntnisse
13:45		A $10,000 Investment 5 Years Ago in This Once-Unstoppable Stock Would Be Worth $463 Today. History Says This Is What It Would Take for Investors to Double Their Money in 5 Years.
13:36		Saratoga Investment Pushes Debt Maturity To 2031, But Dividend Coverage Remains Under Pressure
13:35		Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations
13:30		The Bond Market Is Doing Something That Hasn't Been Observed in Nearly 20 Years. Should Investors Be Nervous?
13:30		Billionaire Bill Ackman Is Buying Microsoft Stock. Is It Still the Best Artificial Intelligence (AI) Buy Today?
13:28		CoreWeave Stock Trending as Company Lands Deals With Hudson River Trading, Rescale
13:25		Anthropic spendiert seiner KI Claude einen eigenen Browser
13:22		How To Earn $500 A Month From Gap Stock Ahead Of Q2 Earnings
13:20		What If AI Could Help Blind Workers See? Meta Glasses Are Transforming Warehouse Jobs While Drones Count Inventory in Minutes
13:20		Okta CEO Says AI Agent Security Could Become Cyber’s Biggest New Market
13:20		Tim Cook Delivered a 2,150% Return for Apple Shareholders Over 15 Years as CEO. Is John Ternus Built to Extend That Run?
13:15		If You Buy Costco Stock With $10,000 Today, I Predict It Could Be Worth $13,400 in 5 Years
13:14		Autodesk Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
13:13		Ulta Beauty Has Topped EPS Estimates for Four Straight Quarters — What About Thursday?
13:11		HMRC reports record capital gains tax haul after Reeves’ rate rise
13:10		History Says This Is What Will Happen to Broadcom Stock After Sept. 2
13:05		Elon Musk Calls Gavin Newsom's California High-Speed Rail Project a 'Big Scam' as Ron DeSantis Says Cost Is 'Mind Blowing'
13:03		What's Going On With Accenture Stock Thursday?

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Circuit Research Laboratories Citizens Financial a Clear Choice Financial Cloverlay Cobham

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	27.08.2026 18:11
Kaufwert:	EUR
	Hinzufügen Speichern

Chugai Pharmaceutical Aktie

WKN DE: A12ABF / ISIN: US1712691039

Chugai Pharmaceutical Times and Sales (NASO)

Analysen zu Chugai Pharmaceutical Co Ltd Unsponsored American Deposit Receipt Repr 2 Shs

Weitere Meldungen